Qingdao Haier Biomedical Co.,Ltd (SHA:688139)

SHA:688139 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,711	11,112	12,824	20,078	28,796	20,702
Market Cap Growth	22.11%	-13.35%	-36.13%	-30.28%	39.10%	126.07%
Enterprise Value	8,265	9,530	10,935	17,327	25,931	18,996
Last Close Price	30.90	34.67	39.39	61.04	86.98	62.29
PE Ratio	28.84	30.31	31.58	33.42	34.08	54.34
Forward PE	22.34	17.53	18.53	25.87	39.80	50.27
PS Ratio	4.25	4.87	5.62	7.01	13.55	14.77
PB Ratio	2.06	2.41	2.89	4.84	7.91	7.44
P/TBV Ratio	2.94	3.46	3.98	6.17	9.42	9.25
P/FCF Ratio	70.63	67.36	177.91	59.37	74.39	34.07
P/OCF Ratio	38.59	38.10	51.45	31.75	48.66	29.72
EV/Sales Ratio	3.62	4.17	4.79	6.05	12.20	13.55
EV/EBITDA Ratio	21.49	23.17	26.63	27.65	52.80	58.29
EV/EBIT Ratio	30.21	31.08	34.94	30.69	58.67	62.69
EV/FCF Ratio	60.11	57.77	151.70	51.24	66.99	31.26
Debt / Equity Ratio	0.01	0.01	0.00	0.01	0.00	0.01
Debt / EBITDA Ratio	0.07	0.06	0.04	0.04	0.01	0.08
Debt / FCF Ratio	0.20	0.14	0.25	0.08	0.02	0.04
Asset Turnover	0.40	0.40	0.41	0.55	0.48	0.40
Inventory Turnover	4.28	4.09	4.53	4.84	3.58	3.93
Quick Ratio	2.28	2.09	2.27	2.68	2.69	2.36
Current Ratio	2.96	2.59	2.69	2.95	3.02	2.62
Return on Equity (ROE)	7.67%	8.41%	9.60%	15.72%	26.44%	14.65%
Return on Assets (ROA)	2.97%	3.39%	3.55%	6.79%	6.25%	5.42%
Return on Capital (ROIC)	3.67%	4.21%	4.53%	9.03%	8.56%	7.19%
Return on Capital Employed (ROCE)	5.60%	6.40%	6.80%	13.10%	11.80%	10.50%
Earnings Yield	3.49%	3.30%	3.17%	2.99%	2.94%	1.84%
FCF Yield	1.42%	1.49%	0.56%	1.68%	1.34%	2.94%
Dividend Yield	1.52%	1.36%	1.31%	0.74%	0.57%	0.61%
Payout Ratio	48.09%	44.48%	35.16%	27.04%	14.30%	14.98%
Buyback Yield / Dilution	-0.37%	0.37%	0.20%	-0.06%	2.43%	-30.55%
Total Shareholder Return	1.17%	1.73%	1.51%	0.68%	3.01%	-29.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.